Alzheimer's disease (AD) progression is highly heterogeneous and is typically observed through sparse and irregular longitudinal data, posing challenges for prediction and personalised monitoring. Existing machine learning approaches have improved AD prediction using multimodal data, yet often focus on static classification or cohort-level risk estimation, providing limited support for subject-specific modelling and uncertainty-aware reasoning.
arXiv:2606. 09671v1 Announce Type: cross Abstract: Alzheimer's disease (AD) progression is highly heterogeneous and is typically observed through sparse and irregular longitudinal data, posing challenges for prediction and personalised monitoring.
By Yinyu Huang, Yilin Zhang, Sofia Michopoulou, Christopher Kipps, Rahman Attar
arXiv:2606. 18571v1 Announce Type: new Abstract: Mild Cognitive Impairment (MCI) is a medical condition characterized by a noticeable decline in memory, language, or thinking abilities.
By William Nguyen, Jiali Cheng, Hadi Amiri
arXiv:2607. 21496v1 Announce Type: cross Abstract: Cognitive impairment (CI) is a growing public health concern.
By Yingchao Huang, Xin Wang, Yuhan Su, Shanshan Yao
arXiv:2606. 00345v1 Announce Type: new Abstract: Wearable and mobile sensing technologies enable continuous monitoring of human behavior and health in real-world settings.
By Flavio Di Martino, Mattia G. Campana, Marcello Magno, Lorenza Pratali, Franca Delmastro
arXiv:2608. 16507v1 Announce Type: new Abstract: Due to the limited amount of information, modeling longitudinal rare-disease data can benefit from integrating clinical knowledge.
By Clemens Sch\"achter, Astrid Pechmann, Janbernd Kirschner, Jan Hasenauer, Harald Binder